Related content

The protein kinase A in platelets from patients with panic disorder

By Tardito D.   Zanardi R.   Racagni G.   Manzoni T.   Perez J.  

European Neuropsychopharmacology, Vol. 12, Iss. 5, 2002-10 ,pp. : 483-487

Elsevier

Access to resources Recommend Favorite

Regulators of G Protein Signaling: Potential Drug Targets for Controlling Cardiovascular and Immune Function

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 107-118

Bentham Science Publishers

Access to resources Recommend Favorite

Aggrenox^® (Extended-Release Dipyridamole and Low-Dose Aspirin in Combination): Protecting Platelets from Excessive Activation in Patients with Vascular Events

By  

Heart Drug, Vol. 2, Iss. 2, 2002-06 ,pp. : 93-104

Karger

Access to resources Recommend Favorite

Cyclooxygenase-2 protein and prostaglandin E 2 production are up-regulated in a rat bladder inflammation model

By Wheeler M.A.   Yoon J.H.   Olsson L.E.   Weiss R.M.  

European Journal of Pharmacology, Vol. 417, Iss. 3, 2001-04 ,pp. : 239-248

Elsevier

Access to resources Recommend Favorite

The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia

By Tardito D.   Maina G.   Tura G.B.   Bogetto F.   Pioli R.   Ravizza L.   Racagni G.   Perez J.  

European Neuropsychopharmacology, Vol. 11, Iss. 3, 2001-06 ,pp. : 221-225

Elsevier

Access to resources Recommend Favorite